Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 85/100

Failure Rate

25.0%

2 terminated/withdrawn out of 8 trials

Success Rate

60.0%

-26.5% vs industry average

Late-Stage Pipeline

0 trials in Phase 3/4

Results Transparency

0 of 3 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

N/A

4(80.0%)

Phase 2

1(20.0%)

5Total

N/A(4)

Phase 2(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (8)

Showing 8 of 8 trials

NCT07155603Not ApplicableNot Yet Recruiting

Visual Aids for Colonoscopy Preparation: A Prospective Study on Patient Understanding and Bowel Cleanliness in Colonoscopy Patients

Role: lead

NCT03984253Recruiting

Swiss Severe Asthma Register

Role: lead

NCT02386735Not ApplicableTerminated

Reduction of Corticosteroid Use in Outpatient Treatment of Exacerbated COPD

Role: lead

NCT04536350Phase 2Terminated

Inhaled Aviptadil for the Treatment of COVID-19 in Patients at High Risk for ARDS

Role: lead

NCT02065921Unknown

Swiss Chronic Obstructive Pulmonary Disease (COPD) Management Cohort

Role: lead

NCT04525820Not ApplicableCompleted

High Dose Vitamin-D Substitution in Patients With COVID-19: a Randomized Controlled, Multi Center Study

Role: lead

NCT04471610Not ApplicableCompleted

Point Of Care With Serial NT-proBNP Measurement in Patients With Acute Decompensation of Heart Failure

Role: lead

NCT03243773Completed

Evaluation of Lung Ultrasound in Acute Heart Failure

Role: lead

All 8 trials loaded